PRESS RELEASE published on 07/30/2024 at 22:30, 1 year 10 months ago DBV Technologies présente les dernières avancées du programme Viaskin Peanut chez les enfants de 4 à 7 ans et les tout-petits de 1 à 3 ans et publie ses résultats financiers du deuxième trimestre et premier semestre 2024. DBV Technologies présente les avancées du programme Viaskin Peanut chez les enfants de 4 à 7 ans et tout-petits de 1 à 3 ans. Résultats financiers publiés pour 2024. Prochain recrutement prévu au 3e trimestre 2024 Résultats Financiers Recrutement DBV Technologies Enfants Viaskin Peanut
PRESS RELEASE published on 07/30/2024 at 22:30, 1 year 10 months ago DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results DBV Technologies provides updates on Viaskin Peanut Program for children and toddlers, reports Q2 and half-year 2024 financial results. Read about VITESSE and COMFORT Toddlers trials and cost-saving measures extending cash runway Financial Results Children DBV Technologies Viaskin Peanut Toddler
BRIEF published on 07/29/2024 at 07:35, 1 year 10 months ago DBV Technologies to Announce Q2 2024 Financial Results Webcast Financial Update DBV Technologies Q2 2024 Results Viaskin Platform
BRIEF published on 07/29/2024 at 07:35, 1 year 10 months ago DBV Technologies annoncera ses résultats financiers du deuxième trimestre 2024 Webdiffusion Mise À Jour Financière DBV Technologies Résultats Du Deuxième Trimestre 2024 Plateforme Viaskin
PRESS RELEASE published on 07/29/2024 at 07:30, 1 year 10 months ago DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024 DBV Technologies to host conference call and webcast to review second quarter 2024 financial results and business update on July 30, 2024. Focus on food allergy treatments Financial Results Conference Call Immunotherapy DBV Technologies Food Allergies
PRESS RELEASE published on 07/29/2024 at 07:30, 1 year 10 months ago DBV Technologies présente ses résultats financiers du premier semestre 2024 et fait le point sur l’évolution de ses activités DBV Technologies annonce ses résultats financiers du premier semestre 2024 et une conférence le jeudi 30 juillet 2024. L'entreprise se spécialise dans le traitement des allergies alimentaires Résultats Financiers Biopharmaceutique Conférence Téléphonique DBV Technologies Allergies Alimentaires
BRIEF published on 07/08/2024 at 22:35, 1 year 10 months ago Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF Contrat De Liquidité Bilan Semestriel ODDO BHF Transactions Boursières DBV Technologies
BRIEF published on 07/08/2024 at 22:35, 1 year 10 months ago Half-yearly review of the DBV Technologies liquidity contract with ODDO BHF Liquidity Contract ODDO BHF Stock Transactions DBV Technologies Half-yearly Review
PRESS RELEASE published on 07/08/2024 at 22:30, 1 year 10 months ago Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF DBV Technologies publie le bilan semestriel de son contrat de liquidité avec ODDO BHF, incluant les moyens en actions et en euros, ainsi que les transactions effectuées Contrat De Liquidité Bilan Semestriel Transactions ODDO BHF DBV Technologies
Published on 06/02/2026 at 11:00, 1 hour 28 minutes ago Snipp Interactive Reports Q1 2026 Financial Results; Bookings Backlog Reaches Record $20.6 Million; Announces Conference Call on Wednesday, June 3, 2026Vancouver, BC, Canada - June 2, 2026
Published on 06/02/2026 at 11:00, 1 hour 28 minutes ago American Critical Minerals to Attend Benchmark Mineral Intelligence's GIGA USA 2026 Conference as Company focuses on US Govt. Initiatives
Published on 06/02/2026 at 09:01, 3 hours 27 minutes ago Star Copper Begins Drilling at Star East Target as 15,000 Metre 2026 Exploration Campaign Gets Underway
Published on 06/02/2026 at 04:00, 8 hours 28 minutes ago Lobe Sciences Announces Proposed Shares for Debt Transaction
Published on 06/02/2026 at 03:00, 9 hours 28 minutes ago Clean Air Metals Files Audited Annual Financial Statements for the Year Ended January 31, 2026
Published on 06/02/2026 at 11:17, 1 hour 10 minutes ago Borussia Dortmund is one of the most valuable soccer clubs in the world
Published on 06/02/2026 at 11:02, 1 hour 25 minutes ago AUSTRIACARD HOLDINGS Launches Stellar Metal Card Collection, Redefining the Future of Premium Payment
Published on 06/02/2026 at 10:48, 1 hour 39 minutes ago VIB Vermögen AG: Joint Venture with a fund managed by Tristan Capital Partners for the development of logistics real estate
Published on 06/02/2026 at 10:05, 2 hours 22 minutes ago Galorath's 2026 State of the Industry Report Finds 79% of Organizations Increased AI Spending on Estimation While Only 1 in 4 Have Clear AI Policies
Published on 06/02/2026 at 10:05, 2 hours 22 minutes ago JK Tech Launches Dedicated Gemini Enterprise Unit to Accelerate AI Adoption Across Enterprises
Published on 06/02/2026 at 08:00, 4 hours 28 minutes ago EURAZEO’S PRIVATE DEBT FUND CLOSES AT RECORD €3.9 BILLION, EXCEEDING ITS INITIAL TARGET
Published on 06/02/2026 at 08:00, 4 hours 28 minutes ago EURAZEO FINALISE LE CLOSING DE SON FONDS DE DETTE PRIVÉE À UN NIVEAU RECORD DE 3,9 MILLIARDS D’EUROS, AU-DELÀ DE SON OBJECTIF INITIAL
Published on 06/02/2026 at 07:30, 4 hours 58 minutes ago OPmobility strengthens its U.S. footprint with a new state-of-the-art plant in the Midwest
Published on 06/02/2026 at 07:30, 4 hours 58 minutes ago OPmobility renforce sa présence aux États-Unis avec une nouvelle usine à la pointe de la technologie dans le Midwest
Published on 06/02/2026 at 07:00, 5 hours 28 minutes ago Point d'étape stratégique pour Biophytis : Dossier de joint-venture déposé à Hong Kong